IsomAb Ltd, a UK-based biotechnology company developing novel isoform-specific disease modifying antibody treatments, for peripheral arterial disease and other ischaemic conditions, today announced ...
Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and ...
"When I was navigating going into the field of medicine there weren't a lot of people who looked like me and that makes it challenging so I wanted to be able to be that representation for them that I ...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results